Regarding the article “Cost analysis of drug treatment in hypertensive patients at social security health care family medicine units”

de Medicina A.H.-B.E.; de Medicina G.F.-O.E.; Oftal D.C.-S. · Salud Publica de Mexico (2023) · DOI: 10.21149/14048

Resumen

Dear editor: We have read with interest the article by Figueroa and colleagues entitled “Cost analysis of drug treatment in hypertensive patients at social security health care family medicine units”.1 We want to express our observations regarding the methodology used in this study The economic studies are based on the original statement of the Consolidated Standards of Health Economic Evaluation Reporting (CHEERS).2 In this article are not informed the items related to the discount rate, cost analysis, and time horizon, that are essential parameters in the validity of this type of studies.

Instituciones: Universidad Privada San Juan Bautista